Furthermore, recent studies highlight that, in addition to classical opioid receptors, the OGF–OGFR signaling axis participates in broader tumor-associated processes, including modulation of inflammatory signaling, microenvironmental interactions, and responses to cytotoxic stress [33,34]. The gene discussed is PENK; the disease is neoplasm.